Stephens Upgrades Neogenomics (NEO) to Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts NEO Hot Sheet
Price: $17.25 +2.19%
Rating Summary:
15 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 13 | New: 42
Rating Summary:
15 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 13 | New: 42
Join SI Premium – FREE
Stephens analyst Mason Carrico upgraded Neogenomics (NASDAQ: NEO) from Equal Weight to Overweight with a price target of $18.00 (from $16.00).
For an analyst ratings summary and ratings history on Neogenomics click here. For more ratings news on Neogenomics click here.
Shares of Neogenomics closed at $13.55 yesterday.
You May Also Be Interested In
- Freedom Broker Upgrades JPMorgan (JPM) to Buy, 'Greater Upside Potential'
- Tele2 AB (TEL2B:SS) (TLTZY) PT Raised to SEK148 at Deutsche Bank
- DSV A/S (DSV:DC) (DSDVF) PT Lowered to DKK1,425 at Deutsche Bank
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
